CME and CFTC Engage in Heated Battle Over On-Chain Perpetual Futures

The ongoing dispute between the Commodity Futures Trading Commission (CFTC) and the CME Group, the largest derivatives exchange operator in the US, has reached a critical point. The controversy centers around the CFTC's decision to allow the listing of blockchain-based perpetual futures products, which the CME claims is a misapplication of the law. The CME argues that these products, known as perps, are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the potential consequences. The lawsuit filed by the CME against the CFTC challenges the regulator's decision to let the prediction markets platform Kalshi and cryptocurrency exchange Coinbase list crypto perps, which are decentralized derivative contracts that enable users to speculate on the price of an asset with leverage and no expiration date. The CME claims that the CFTC is mislabeling these products and, as a result, misapplying the law, as futures contracts require an end date. The CFTC's approval of perps has been met with frustration and outrage from some quarters, with critics arguing that the regulator is not considering the potential risks and ramifications of these products. The dispute has significant implications for the US approach to the rapidly growing market for perpetual futures, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME's lawsuit argues that the CFTC's decision to allow perps is a deviation from established laws and regulations, and that the regulator is not prepared to enforce its emerging perps policy properly. The CFTC, on the other hand, maintains that its decision to allow perps is a necessary step to facilitate innovation and competition in the market. The outcome of this dispute will have far-reaching consequences for the US derivatives market and the regulation of perpetual futures products.